• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感疫苗接种后的死亡——背景死亡率还是因果关系?

Deaths following influenza vaccination--background mortality or causal connection?

作者信息

Kokia Ehud S, Silverman Barbara G, Green Manfred, Kedem Hagai, Guindy Michal, Shemer Joshua

机构信息

Maccabi Healthcare Services, 27 HaMered Street, Tel Aviv, Israel.

出版信息

Vaccine. 2007 Dec 12;25(51):8557-61. doi: 10.1016/j.vaccine.2007.10.021. Epub 2007 Oct 29.

DOI:10.1016/j.vaccine.2007.10.021
PMID:18006121
Abstract

In October 2006, four deaths occurred in Israel shortly after influenza immunization, resulting in a temporary halt to the vaccination campaign. After an epidemiologic investigation, the Ministry of Health concluded that these deaths were not related to the vaccine itself and the campaign resumed; however, vaccine uptake was markedly reduced. Estimates of true background mortality in this high-risk population would aid in public education and quell unnecessary concerns regarding vaccine safety. We used data from a large HMO to estimate mortality in influenza vaccine recipients aged 55 and over during four consecutive winters (2003, 2004, 2005 and 2006). Date of immunization was ascertained from patient treatment files, vital status through Israeli National Insurance Institute data. We calculated crude death rates within 7, 14 and 30 days of influenza immunization, and used a Cox Proportional Hazards Model to estimate the risk of death within 14 days of vaccination, adjusting for age and comorbid conditions (age over 75, history of diabetes or cardiovascular disease, status as homebound patient) in 2006. The death rate among influenza vaccine recipients ranged from 0.01 to 0.02% within 7 days and 0.09-0.10% at 30 days. Influenza immunization was associated with a decreased risk of death within 14 days after adjustment for comorbidities (Hazard ratio, 0.33, 95% CI, 0.18-0.61). Our findings support the assumption that influenza vaccination is not associated with increased risk of death in the short term.

摘要

2006年10月,以色列在流感疫苗接种后不久发生了4例死亡病例,导致疫苗接种活动暂时停止。经过流行病学调查,卫生部得出结论,这些死亡与疫苗本身无关,接种活动得以恢复;然而,疫苗接种率显著下降。估计这一高危人群的实际背景死亡率将有助于开展公众教育,并平息对疫苗安全性的不必要担忧。我们使用来自一家大型健康维护组织(HMO)的数据,估算了连续四个冬季(2003年、2004年、2005年和2006年)55岁及以上流感疫苗接种者的死亡率。从患者治疗档案中确定免疫接种日期,通过以色列国家保险研究所的数据确定生命状态。我们计算了流感疫苗接种后7天、14天和30天内的粗死亡率,并使用Cox比例风险模型估算接种疫苗后14天内的死亡风险,对2006年的年龄和合并症(75岁以上、糖尿病或心血管疾病史、居家患者状态)进行了调整。流感疫苗接种者的死亡率在7天内为0.01%至0.02%,在30天内为0.09%至0.10%。在对合并症进行调整后,流感疫苗接种与14天内死亡风险降低相关(风险比,0.33,95%置信区间为0.18 - 0.61)。我们的研究结果支持这样的假设,即流感疫苗接种在短期内不会增加死亡风险。

相似文献

1
Deaths following influenza vaccination--background mortality or causal connection?流感疫苗接种后的死亡——背景死亡率还是因果关系?
Vaccine. 2007 Dec 12;25(51):8557-61. doi: 10.1016/j.vaccine.2007.10.021. Epub 2007 Oct 29.
2
A cluster of deaths following influenza vaccination, Israel, 2006.2006 年以色列流感疫苗接种后出现的死亡集群。
J Public Health Policy. 2010 Sep;31(3):318-23. doi: 10.1057/jphp.2010.22.
3
Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease.年度流感疫苗接种对老年慢性心脏病患者冬季死亡率的影响。
Eur Heart J. 2009 Jan;30(2):209-16. doi: 10.1093/eurheartj/ehn498. Epub 2008 Nov 8.
4
[Adverse events following influenza vaccination: reaction to specific reports and the necessity of a central registration system].[流感疫苗接种后的不良事件:对特定报告的反应及中央登记系统的必要性]
Ned Tijdschr Geneeskd. 2007 Sep 29;151(39):2166-9.
5
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors.功能状态是流感疫苗与老年人全因死亡率风险之间关联的一个混杂因素。
Int J Epidemiol. 2006 Apr;35(2):345-52. doi: 10.1093/ije/dyi275. Epub 2005 Dec 20.
6
Compliance with influenza vaccination in Israel in two successive winters, 1998/1999 and 1999/2000.以色列在1998/1999年和1999/2000年连续两个冬季流感疫苗接种的依从情况。
Isr Med Assoc J. 2000 Oct;2(10):742-5.
7
Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study.65岁以下患有高危疾病人群接种流感疫苗的临床效果:PRISMA研究
Arch Intern Med. 2005 Feb 14;165(3):274-80. doi: 10.1001/archinte.165.3.274.
8
Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage.意大利老年人中与流感相关的死亡率:未随疫苗接种覆盖率的提高而下降。
Vaccine. 2006 Oct 30;24(42-43):6468-75. doi: 10.1016/j.vaccine.2006.06.052. Epub 2006 Jul 7.
9
Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease.年度流感疫苗接种对慢性肺病老年人冬季死亡率的影响。
Int J Clin Pract. 2008 Jan;62(1):10-7. doi: 10.1111/j.1742-1241.2007.01414.x. Epub 2007 Jun 15.
10
Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season.流感疫苗接种:2000 - 2001年流感季节期间“马卡比医疗服务机构”成员住院率和死亡率的降低情况。
Isr Med Assoc J. 2003 Oct;5(10):706-8.

引用本文的文献

1
The expected number of background disease events during mass immunization in China.中国大规模免疫接种期间预期的基础疾病事件数。
PLoS One. 2013 Aug 20;8(8):e71818. doi: 10.1371/journal.pone.0071818. eCollection 2013.
2
Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study.利用基于人群的疾病背景发生率评估丹麦儿童期疫苗安全性和大规模免疫接种:全国范围内基于人群的队列研究。
BMJ. 2012 Sep 17;345:e5823. doi: 10.1136/bmj.e5823.
3
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.
在大规模式人群接种甲型 H1N1 流感疫苗时评估疫苗安全性时疾病背景发生率的重要性。
Lancet. 2009 Dec 19;374(9707):2115-2122. doi: 10.1016/S0140-6736(09)61877-8. Epub 2009 Oct 31.